Devlin Medical Launching at Medica 2009

Devlin Medical will be launched at the Medica Forum and Exhibition in Dusseldorf from November 18th to the 21st. Devlin Medical is a new division of Devlin Electronics and is dedicated to the development of innovative point-of-care computing solutions.

Devlin have been working within the healthcare sector since signing an exclusive European distribution agreement with, American company, Datalux in 2004. This includes the highly respected IPIX medical grade all-in-one PC & Monitor. Devlin's years of experience help them understand what makes the European market so unique.

"Customisation is vital," explains Devlin Electronics Managing Director, Martin Baker. "From what we understand of the US market the most of cart deployments are based on standard products. In Europe the thinking is often far more application specific. We see much greater demand for custom alterations and that we are more than happy to undertake."

It is believed that the launch of Devlin Medical as a division of Devlin Electronics will reap great benefits. Devlin Medical will draw on a dedicated team of engineers and technicians whose sole responsibility will be to create custom mobile computer solutions designed to meet specific user requirements.

"In the years since we started working with Datalux we have created our own range of standard carts, ideally suited to the European market, they can be used for the deployment of all-in-one PCs, laptops, tablet PCs, small form factor PCs and even thin client PCs. It has always been our intention to not only offer standard products but to be responsive to user driven custom design. We want our products to fit the way a clinician works rather than a clinician having to alter their working patterns to fit a computer cart. The first question we always ask clients is, great you want a cart for mobile computer access but what else do you need it to do?" Baker explained.

The Devlin stand will feature a range of mobile solutions with expert staff on hand to discuss custom design concepts. They are part of the UK Trade pavilion in Hall 16 Stand G04-7.

"We have over 30 years experience in custom design and manufacture, quite simply, you will not find such experience with any other cart manufacturer. We feel it is this strong track record that is seeing us expand successfully not only in the UK but across Europe. We are winning customers because we really can supply a mobile computing cart unique to your application." concludes Baker.

For further information, please visit:
http://www.devlinmedical.co.uk

Since 2004 Devlin has seen its reputation grow within the UK healthcare industry and has been involved in numerous large scale cart deployments (A case study on one deployment within the Cardiff and Vale NHS Trust in Wales is available on request). This will be Devlin's third year exhibiting at Medica, in that time they have seen major growth in the demand for mobile computing carts in Europe. Devlin already have a broad distributor network established in Europe to aid their overseas growth but always view Medica as an opportunity to meet first hand with customers to learn about new requirements and trends but also to meet with potential distributors in regions that as yet do not have Devlin representation.

Most Popular Now

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI Model Converts Hospital Records into …

UCLA researchers have developed an AI system that turns fragmented electronic health records (EHR) normally in tables into readable narratives, allowing artificial intelligence to make sense of complex patient histories...

AI Sharpens Pathologists' Interpret…

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately...

AI Tool Detects Surgical Site Infections…

A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with high accuracy from patient-submitted postoperative wound photos, potentially transforming...

Forging a Novel Therapeutic Path for Pat…

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...